Clinical Trials Directory

Trials / Completed

CompletedNCT02747641

Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Alma Lasers Inc. · Industry
Sex
Female
Age
35 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the use of the Alma CO2 Pixel FemiLift™ in the treatment of VulvoVaginal Atrophy (VVA) in postmenopausal female subjects. The primary endpoint is to assess the change in the vaginal dryness by means of a Visual Analogic Scale (10 cm VAS) and/or Bachmann Index in VVA. The clinical improvement will be assessed by patient filled Vulvovaginal Atrophy.

Conditions

Interventions

TypeNameDescription
PROCEDUREPixel CO2 Laser System

Timeline

Start date
2016-05-01
Primary completion
2016-12-01
Completion
2017-08-01
First posted
2016-04-22
Last updated
2017-11-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02747641. Inclusion in this directory is not an endorsement.